Evolving Management of Hip Fracture Patients on Anticoagulant and Antiplatelet Medications: A 22-Year Cohort Study

医学 华法林 抗血栓 围手术期 抗凝剂 养生 回顾性队列研究 氯吡格雷 优势比 髋部骨折 抗血小板药物 抗凝药 外科 队列研究 阿司匹林 队列 内科学 心房颤动 麻醉 血小板聚集抑制剂 髋关节手术 共病 关节置换术 可能性 药方 血栓形成 纤溶剂 肝素 输血 比伐卢定
作者
Hanna E. House,Austin Schwartz,Michelle Shimizu,Insup Hong,Joseph Cohen,Hobie D. Summers,Ashley E. Levack
出处
期刊:Journal of Orthopaedic Trauma [Lippincott Williams & Wilkins]
标识
DOI:10.1097/bot.0000000000003314
摘要

OBJECTIVES: To evaluate temporal trends in anticoagulant (AC) and antiplatelet (AP) use among patients undergoing operative treatment of hip fractures and to assess the association of antithrombotic regimen with time to surgery and postoperative outcomes. METHODS: Design: Retrospective cohort study. SETTING: Single North American Level I trauma center. PATIENT SELECTION CRITERIA: Patients aged 55 years or older who underwent operative treatment for a hip fracture (AO/OTA types 31-A, 31-B, and 31-C) between 2000 and 2022 while receiving anticoagulant and/or antiplatelet therapy at admission were included. OUTCOME MEASURES AND COMPARISONS: Temporal trends in antithrombotic prescribing, time to surgery, perioperative transfusion, readmission, 90-day medical and surgical postoperative complications, and 90-day mortality were assessed. The odds of warfarin versus direct oral anticoagulant (DOAC) prescription were compared across study years, and time to surgery from admission and each outcome were compared across study years and across antithrombotic regimens (warfarin, DOAC, DOAC or warfarin plus antiplatelet, and antiplatelet alone). RESULTS: 476 patients were included (mean age 81.2 years [range, 60-103]; 288 [60.4%] female). Anticoagulant therapy was used by 155 (32.7%) and antiplatelet therapy by 385 (80.7%); 64 (13.4%) received both. The odds of warfarin prescription relative to a DOAC decreased by an estimated 37% per year (odds ratio [OR] 0.63, 95% CI 0.53-0.74; P<0.001). Time to surgery did not change significantly over the study period (-0.01 hours/year, 95% CI -0.04 to 0.02; P=0.4) and was not associated with antithrombotic regimen (-0.01, 95% CI: -0.04-0.01; P=0.3). Perioperative transfusion odds decreased 12% per year (OR 0.88, 95% CI 0.84-0.93; P<0.001) and 1-year readmission odds decreased 46% per year (OR 0.54, 95% CI 0.48-0.60; P<0.001), independent of medication class. Ninety-day (OR 0.99, 95% CI 0.95-1.04; P=0.8) and 90-day mortality (OR 0.79, 95% CI 0.54-1.14; P=0.2) did not change over time. CONCLUSIONS: In this 22-year single-center cohort of hip-fracture patients receiving anticoagulant (AC) or antiplatelet (AP) therapy, antithrombotic regimen was not associated with time to surgery, 90-day complications, or mortality. Perioperative transfusion and 1-year readmission rates declined over the study period independent of medication class. These findings supported expedited operative management of hip fractures in patients receiving AC or AP therapy. LEVEL OF EVIDENCE: III.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
852的应助被猪猪猪采纳,获得10
刚刚
TOMORROW发布了新的文献求助10
刚刚
kk发布了新的文献求助10
1秒前
年轻映安发布了新的文献求助10
1秒前
2秒前
hiraabb完成签到 ,获得积分10
2秒前
xxxhhaoxxx发布了新的文献求助10
3秒前
00hello00发布了新的文献求助10
3秒前
寒鸦浮水完成签到,获得积分10
4秒前
独孤蚕完成签到,获得积分10
4秒前
隐隐发布了新的文献求助10
4秒前
炜豪发布了新的文献求助10
5秒前
科研通AI6.2的应助被匆匆采纳,获得10
5秒前
南科易梦发布了新的文献求助10
6秒前
菠萝完成签到 ,获得积分10
6秒前
Lucas的应助被乌贼爱吃采纳,获得10
7秒前
善良的汉堡完成签到 ,获得积分10
7秒前
mmm发布了新的文献求助10
7秒前
研友_VZG7GZ的应助被Yoghurt采纳,获得30
7秒前
7秒前
7秒前
8秒前
heng发布了新的文献求助38
8秒前
8秒前
雪白玲完成签到,获得积分10
8秒前
LYK完成签到,获得积分10
10秒前
苹果从梦完成签到,获得积分10
11秒前
Singel完成签到,获得积分10
11秒前
zzz完成签到 ,获得积分20
12秒前
12秒前
12秒前
syvshc的应助被Waitcy采纳,获得10
13秒前
13秒前
多情的仰发布了新的文献求助10
14秒前
瓜瓜发布了新的文献求助10
14秒前
慕青的应助被yshog采纳,获得10
14秒前
小龙完成签到 ,获得积分10
14秒前
15秒前
15秒前
现在发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194041
求助须知:如何正确求助?哪些是违规求助? 9579979
关于积分的说明 21868799
捐赠科研通 7793641
什么是DOI,文献DOI怎么找? 3437477
关于科研通互助平台的介绍 2560942
邀请新用户注册赠送积分活动 2484251